Stanford doctors develop first FDA-approved gene-editing tre

The FDA recently approved Casgevy, a gene-editing medical treatment which uses CRISPR/Cas9 technology to treat sickle cell disease. Casgevy, which two Stanford faculty members contributed to via drug development and FDA approval, is the first gene-editing medical treatment to recieve FDA approval.

Related Keywords

United States , Americans , Joseph Wu , Jennifer Doudna , Emmanuelle Charpentier , Paulo Henrique Orlandi Mourao , Matthew Porteus , Stanley Qi , Stanford Cardiovascular Institute , Drug Administration , Stanford Professor , Stanford Medicine , Nobel Prize , Associate Professor , Scientific Founder ,